| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce92a4d2fdab0cc5440f710c3787f38 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2004-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ad6e30ab388956f7ab8262f331f161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_973b4b3f185cdc4857ea9680af72bad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0550de8b8d0a77ba41e26de53025e68 |
| publicationDate |
2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-545764-A |
| titleOfInvention |
Amino-substituted ethylamino B2 adrenergic receptor agonists |
| abstract |
Disclosed is a compound of formula (I) wherein the substituents are defined within the specification or a pharmaceutically-acceptable salt or solvate or stereoisomer thereof. Also disclosed is a method of preparing a compound of formula (I). Also disclosed is using the compound of formula (I) for manufacturing a medicament for the treatment of a disease or condition associated with beta2 adrenergic receptor activity such as a pulmonary disease or condition. |
| priorityDate |
2003-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |